TY - JOUR
T1 - Tracking Changes in Mobility Before and After the First SARS-CoV-2 Vaccination Using Global Positioning System Data in England and Wales (Virus Watch)
T2 - Prospective Observational Community Cohort Study
AU - Nguyen, Vincent
AU - Liu, Yunzhe
AU - Mumford, Richard
AU - Flanagan, Benjamin
AU - Patel, Parth
AU - Braithwaite, Isobel
AU - Shrotri, Madhumita
AU - Byrne, Thomas
AU - Beale, Sarah
AU - Aryee, Anna
AU - Erica Fong, Wing Lam
AU - Fragaszy, Ellen
AU - Geismar, Cyril
AU - Navaratnam, Annalan M.D.
AU - Hardelid, Pia
AU - Kovar, Jana
AU - Pope, Addy
AU - Cheng, Tao
AU - Hayward, Andrew
AU - Aldridge, Robert
N1 - Publisher Copyright:
© Vincent Nguyen, Yunzhe Liu, Richard Mumford, Benjamin Flanagan, Parth Patel, Isobel Braithwaite, Madhumita Shrotri, Thomas Byrne, Sarah Beale, Anna Aryee, Wing Lam Erica Fong, Ellen Fragaszy, Cyril Geismar, Annalan M D Navaratnam, Pia Hardelid, Jana Kovar, Addy Pope, Tao Cheng, Andrew Hayward, Robert Aldridge.
PY - 2023
Y1 - 2023
N2 - Background: Evidence suggests that individuals may change adherence to public health policies aimed at reducing the contact, transmission, and spread of the SARS-CoV-2 virus after they receive their first SARS-CoV-2 vaccination when they are not fully vaccinated. Objective: We aimed to estimate changes in median daily travel distance of our cohort from their registered addresses before and after receiving a SARS-CoV-2 vaccine. Methods: Participants were recruited into Virus Watch starting in June 2020. Weekly surveys were sent out to participants, and vaccination status was collected from January 2021 onward. Between September 2020 and February 2021, we invited 13,120 adult Virus Watch participants to contribute toward our tracker subcohort, which uses the GPS via a smartphone app to collect data on movement. We used segmented linear regression to estimate the median daily travel distance before and after the first self-reported SARS-CoV-2 vaccine dose. Results: We analyzed the daily travel distance of 249 vaccinated adults. From 157 days prior to vaccination until the day before vaccination, the median daily travel distance was 9.05 (IQR 8.06-10.09) km. From the day of vaccination to 105 days after vaccination, the median daily travel distance was 10.08 (IQR 8.60-12.42) km. From 157 days prior to vaccination until the vaccination date, there was a daily median decrease in mobility of 40.09 m (95% CI –50.08 to –31.10; P<.001). After vaccination, there was a median daily increase in movement of 60.60 m (95% CI 20.90-100; P<.001). Restricting the analysis to the third national lockdown (January 4, 2021, to April 5, 2021), we found a median daily movement increase of 18.30 m (95% CI –19.20 to 55.80; P=.57) in the 30 days prior to vaccination and a median daily movement increase of 9.36 m (95% CI 38.6-149.00; P=.69) in the 30 days after vaccination. Conclusions: Our study demonstrates the feasibility of collecting high-volume geolocation data as part of research projects and the utility of these data for understanding public health issues. Our various analyses produced results that ranged from no change in movement after vaccination (during the third national lock down) to an increase in movement after vaccination (considering all periods, up to 105 days after vaccination), suggesting that, among Virus Watch participants, any changes in movement distances after vaccination are small. Our findings may be attributable to public health measures in place at the time such as movement restrictions and home working that applied to the Virus Watch cohort participants during the study period.
AB - Background: Evidence suggests that individuals may change adherence to public health policies aimed at reducing the contact, transmission, and spread of the SARS-CoV-2 virus after they receive their first SARS-CoV-2 vaccination when they are not fully vaccinated. Objective: We aimed to estimate changes in median daily travel distance of our cohort from their registered addresses before and after receiving a SARS-CoV-2 vaccine. Methods: Participants were recruited into Virus Watch starting in June 2020. Weekly surveys were sent out to participants, and vaccination status was collected from January 2021 onward. Between September 2020 and February 2021, we invited 13,120 adult Virus Watch participants to contribute toward our tracker subcohort, which uses the GPS via a smartphone app to collect data on movement. We used segmented linear regression to estimate the median daily travel distance before and after the first self-reported SARS-CoV-2 vaccine dose. Results: We analyzed the daily travel distance of 249 vaccinated adults. From 157 days prior to vaccination until the day before vaccination, the median daily travel distance was 9.05 (IQR 8.06-10.09) km. From the day of vaccination to 105 days after vaccination, the median daily travel distance was 10.08 (IQR 8.60-12.42) km. From 157 days prior to vaccination until the vaccination date, there was a daily median decrease in mobility of 40.09 m (95% CI –50.08 to –31.10; P<.001). After vaccination, there was a median daily increase in movement of 60.60 m (95% CI 20.90-100; P<.001). Restricting the analysis to the third national lockdown (January 4, 2021, to April 5, 2021), we found a median daily movement increase of 18.30 m (95% CI –19.20 to 55.80; P=.57) in the 30 days prior to vaccination and a median daily movement increase of 9.36 m (95% CI 38.6-149.00; P=.69) in the 30 days after vaccination. Conclusions: Our study demonstrates the feasibility of collecting high-volume geolocation data as part of research projects and the utility of these data for understanding public health issues. Our various analyses produced results that ranged from no change in movement after vaccination (during the third national lock down) to an increase in movement after vaccination (considering all periods, up to 105 days after vaccination), suggesting that, among Virus Watch participants, any changes in movement distances after vaccination are small. Our findings may be attributable to public health measures in place at the time such as movement restrictions and home working that applied to the Virus Watch cohort participants during the study period.
KW - COVID-19
KW - GPS
KW - SARS-CoV-2
KW - geographical tracking
KW - geolocation
KW - global positioning system
KW - health application
KW - mHealth
KW - mobile app
KW - mobile surveillance
KW - movement tracking
KW - public health
KW - surveillance
KW - tracking device
KW - vaccination
UR - http://www.scopus.com/inward/record.url?scp=85149999879&partnerID=8YFLogxK
U2 - 10.2196/38072
DO - 10.2196/38072
M3 - Article
C2 - 36884272
AN - SCOPUS:85149999879
SN - 2369-2960
VL - 9
JO - JMIR Public Health and Surveillance
JF - JMIR Public Health and Surveillance
M1 - e38072
ER -